Core Insights - During the "14th Five-Year Plan" period, Weihai's medical insurance fund operates smoothly, with both employee and resident insurance funds remaining within a sustainable range [1] - The reimbursement ratios for inpatient expenses are stable at over 80% for employees and over 65% for residents, with a 70% reimbursement for key assistance recipients [1] Group 1: Medical Insurance Fund Performance - The outpatient co-payment mechanism has been fully established, with 11.69 million outpatient reimbursements totaling 1.098 billion yuan [1] - Major medical insurance provides a maximum reimbursement rate of 90% for high-cost medical expenses, with cumulative payments of 609 million yuan for major medical insurance and 208 million yuan for medical assistance over five years [1] - Long-term care insurance has achieved full coverage for employees, with pilot programs for residents, totaling 130 million yuan in benefits distributed over five years [1] Group 2: Medical Service Pricing and Reforms - Weihai has conducted 22 dynamic adjustments to medical service prices over five years, adding 105 new service items and adjusting 664 prices [2] - The implementation of DRG payment reform has led to a 16% decrease in average hospitalization costs compared to the end of the "13th Five-Year Plan" [2] - The number of drugs in the medical insurance reimbursement directory has increased from 2,709 to 3,159, with 600 types of negotiated drugs included, enhancing patient access to affordable treatment [2] Group 3: Accessibility and Service Improvements - The network for cross-province medical settlement has expanded significantly, with 144 hospitals and 1,552 pharmacies supporting direct settlement [3] - The activation of medical insurance electronic certificates has reached 2.48 million, with mobile payment coverage exceeding 85% [3] - Six services, including "newborn birth," have been streamlined to allow for single-visit processing, improving the overall experience for the public [3]

Core Insights - The article discusses the impact of healthcare policy reforms on chronic disease patients in China, highlighting the balance between personal account reductions and increased social insurance coverage [1][4][6] Group 1: Policy Changes and Their Effects - The healthcare policy in Jilin Province has undergone three adjustments from 2023 to 2025, significantly reducing out-of-pocket expenses for chronic disease medications [1][4] - The monthly contributions to personal accounts for retirees have decreased from 240 yuan in 2022 to 111 yuan in 2023, and further to 78 yuan in 2024, reflecting a shift towards increased reimbursement rates [2][3] - New outpatient reimbursement policies have been introduced, increasing reimbursement rates by 5% and lowering the threshold for chronic disease patients, thus enhancing financial support for those with chronic conditions [3][4] Group 2: Financial Implications for Patients - Patients like Zhang Guilan and Li Hongmei have reported reduced personal expenses due to the new reimbursement policies, despite lower personal account contributions [3][5] - The introduction of a "public servant medical subsidy" in 2025 aims to provide additional support for retired civil servants, reflecting a targeted approach to healthcare funding [4][6] - The overall trend indicates a move from individual account reliance to a more collective insurance model, enhancing the mutual support capacity of the healthcare system [4][6] Group 3: Broader Implications for Healthcare Access - The reforms aim to address the inequities in healthcare access between urban and rural areas, with improvements in the availability of essential medications in rural health facilities [8][12] - The introduction of chronic disease certificates has significantly reduced medication costs for patients, demonstrating the effectiveness of policy in alleviating financial burdens [9][10] - Future reforms are expected to further expand coverage for chronic diseases and improve the efficiency of the reimbursement process, indicating a commitment to enhancing healthcare access for all [11][12]